Baltimore, MD
Graybug Vision, Inc. operates as a pharmaceutical company. The Company develops drug delivery therapies and sustained-release compounds for the treatment of eye diseases. GrayBug Vision serves patients in the United States.
graybug.comThese are collections Graybug Vision is a part of. Click on the collection name to view similar companies.
IPO
Unknown
Series C
$80,000,000
Series B
$44,500,000
Debt Financing
$750,000
Series A
$1,740,000
Series Unknown
$750,000
Series A
$1,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Graybug Vision.